cost actions on track to deliver over $7 million in savings in fiscal 2021.
qtrly adjusted earnings per share $0.96.
in fiscal q2 2021, standex expects consolidated company revenue to be flat to slightly above fiscal q1 2021.
in fiscal q2 2021, company expects moderate sequential revenue increase at scientific as vaccine storage demand rises.
qtrly net sales $151.3 million versus $156.0 million.
